{
    "clinical_study": {
        "@rank": "131036", 
        "acronym": "NSM", 
        "arm_group": [
            {
                "arm_group_label": "OxyGenesys Dissolved Oxygen Dressing", 
                "arm_group_type": "Active Comparator", 
                "description": "OxyGenesys Dissolved Oxygen Dressing is a closed-cell foam wound dressing enriched with gaseous and dissolved oxygen for use in the management of wounds."
            }, 
            {
                "arm_group_label": "Standard Gauze Dressing", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A sterile 4x4 covered by an adhesive Tegaderm will serve as the comparator for this study."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will evaluate the effect of OxyGenesys Dissolved Oxygen Dressing in wound\n      complication rates of the nipple areolar complex after a nipple sparing mastectomy."
        }, 
        "brief_title": "Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Breast Cancer", 
            "Reconstructive Breast Surgery"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "This study will recruit women who are undergoing a bilateral mastectomy for either cancer or\n      a positive BRCA gene.  Women will be randomized to a different treatment per breast.  One\n      breast will receive the OxyGenesys dressing and the other will receive the standard gauze\n      dressing.  The study will evaluate wound complication rates and compare the two treatments."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is able to give written consent\n\n          -  Females >21 years of age\n\n          -  At least one breast diagnosed with cancer or mastectomy due to a positive   BRCA gene\n             mutation test.\n\n          -  Subject is indicated for bilateral nipple-sparing mastectomy surgery with immediate\n             breast reconstruction\n\n          -  Subject is able to comply with the study protocol\n\n        Exclusion Criteria:\n\n          -  Primary tumor(s) located within 2cm of the areola margins\n\n          -  Inability to perform follow up assessments\n\n          -  Radiation treatment within 30 days of surgery\n\n          -  Dermabond or other forms of surgical glue is used in the peri-areola region\n\n          -  Subjects who are known to be allergic to any of the test product(s) or any component\n             of the test product(s)\n\n          -  Women who are pregnant\n\n          -  Subjects who have been treated with an investigational drug or device within the past\n             30 days prior to enrollment"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01796977", 
            "org_study_id": "100-12-0001"
        }, 
        "intervention": [
            {
                "arm_group_label": "OxyGenesys Dissolved Oxygen Dressing", 
                "intervention_name": "OxyGenesys Dissolved Oxygen Dressing", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Standard Gauze Dressing", 
                "intervention_name": "Standard Gauze Dressing", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Nipple-sparing Mastectomy", 
            "NSM", 
            "Nipple Sparing Mastectomy"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60637"
                    }, 
                    "name": "University of Chicago"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63141"
                    }, 
                    "name": "Bodyaesthetic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Great Neck", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11201"
                    }, 
                    "name": "Aesthetic Plastic Surgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tarrytown", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10591"
                    }, 
                    "name": "New York Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75390"
                    }, 
                    "name": "UT Southwestern"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Multi-Center, Randomized, Open Label Controlled Trial Using a Dissolved Oxygen Enriched Dressing in Nipple-sparing Mastectomy", 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Evaluate the effects of OxyGenesys Dissolved Oxygen Dressing in wound complication rates of the nipple areolar complex post nipple-sparing mastectomy", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01796977"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "To evaluate scar formation 30 days post nipple-sparing mastectomy", 
                "safety_issue": "No", 
                "time_frame": "30 days post nipple-sparing mastectomy"
            }, 
            {
                "measure": "To assess pain using the numeric rating scale", 
                "safety_issue": "No", 
                "time_frame": "48 hours, 6 days, 14 days and 30 days"
            }, 
            {
                "description": "Serious adverse events will be followed to closure.", 
                "measure": "To evaluate the overall adverse events during study participation", 
                "safety_issue": "No", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Kimberly-Clark Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kimberly-Clark Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014", 
        "why_stopped": "inability to enroll in this subject population"
    }
}